Kinrix® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free 25 Lf - 10 Lf - 25 mcg - 80 DU / 0.5 mL Injection 0.5 mL

Name: DTaP and Polio Vaccine
Brand: Kinrix®

KINRIX VACCINE, SYR 25-25-10MG/0.5ML 0.5ML (10/PK)

McKesson #

764549

Manufacturer #

58160081252

Brand

Kinrix®

Manufacturer

Glaxo Smith Kline

Country of Origin

Unknown

Application

DTaP and Polio Vaccine

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

99831

Generic Drug Name

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free

NDC Number

58160081252

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

25 Lf - 10 Lf - 25 mcg - 80 DU / 0.5 mL

Type

Intramuscular

UNSPSC Code

51202100

User

Indicated for People 4 to 6 Years of Age

Volume

0.5 mL

KINRIX may be used for the fifth dose in the DTaP immunization series and the fourth dose in the IPV immunization series in children 4 through 6 years of age (prior to the seventh birthday) whose previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX for the first three doses and INFANRIX for the fourth dose
Prefilled TIP-LOK syringe without needle
Store refrigerated between 2 and 8 degrees C (36 and 46 degrees F)
Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated pertussis toxin (PT), 25 mcg of filamentous hemagglutinin (FHA), 8 mcg of pertactin (69 kiloDalton outer membrane protein), 40 D-antigen Units (DU) of Type 1 poliovirus (Mahoney), 8 DU of Type 2 poliovirus (MEF-1), and 32 DU of Type 3 poliovirus (Saukett)